S
PRAX icon

SignatureFD’s Praxis Precision Medicines PRAX Stock Holding History

SignatureFD’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.03K Sell
21
-9
-30% -$2.85K ﹤0.01% 2767
2026
Q1 		$9.67K Buy
+30
New +$9.28K ﹤0.01% 2527
2022
Q3 		– Sell
-14
Closed -$1K – 3290
2022
Q2 		$1K Sell
14
-6
-30% -$640 ﹤0.01% 2986
2022
Q1 		$3K Sell
20
-7
-26% -$1.44K ﹤0.01% 2713
2021
Q4 		$8K Buy
27
+18
+200% +$5.28K ﹤0.01% 2228
2021
Q3 		$3K Buy
+9
New +$2.44K ﹤0.01% 2546

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

SignatureFD's PRAX Position: Q2 2026 in Review

SignatureFD reduced its Praxis Precision Medicines (PRAX) stake by 30% in Q2 2026, selling an estimated $2.85K and leaving 21 shares worth $7.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2767.

SignatureFD first reported a position in PRAX in Q3 2021 and has held it in 6 quarters since. The position peaked at $9.67K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • SignatureFD held 21 shares of Praxis Precision Medicines worth $7.03K as of Q2 2026.
  • SignatureFD sold 9 Praxis Precision Medicines shares in Q2 2026, an estimated $2.85K.
  • Praxis Precision Medicines made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2767 holding.
  • SignatureFD first reported a position in Praxis Precision Medicines in Q3 2021 and has held it in 6 quarters since.
  • SignatureFD's Praxis Precision Medicines position peaked at $9.67K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.